← Back to headlines





Personalized mRNA Vaccine Shows Promise in Treating Skin Cancer
A personalized mRNA vaccine, when combined with immunotherapy, has shown promising long-term results in reducing the risk of melanoma recurrence, though it awaits approval and is expected to be expensive.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories

FDA Grants Expedited Approval to Landmark Pancreatic Cancer Drug
24m ago

Study Links Shingles Vaccine to Reduced Risk of Heart Attacks and Strokes
24m ago

Busy Philipps Reveals She Underwent Surgery to Remove Rare Brain Tumor
1h ago

Closing Arguments Set as Murder Trial of Chris Benoit Nears Conclusion
1h ago